Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis

Download references

Feng Xie^*, Gord Blackhouse, Nazila Assasi, Kathryn Gaebel, Diana Robertson and Ron Goeree

Cost Effectiveness and Resource Allocation 2009, 7:20 doi:10.1186/1478-7547-7-20

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX